• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.24% Nasdaq Down 1.30%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    136.09 Down 2.73(1.97%) 12:36PM EST - Nasdaq Real Time Price
    Prev Close:138.82
    Open:134.52
    Bid:136.76 x 200
    Ask:137.02 x 100
    1y Target Est:206.11
    Beta:1.59616
    Earnings Date:Apr 21 - Apr 25 (Est.)
    Day's Range:134.40 - 137.63
    52wk Range:130.51 - 208.88
    Volume:528,668
    Avg Vol (3m):1,635,970
    Market Cap:30.66B
    P/E (ttm):203.12
    EPS (ttm):0.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 1.97%30.66B
    AMGNDown 2.02%106.99B
    BAXDown 2.76%19.63B

    Key Statistics

    Forward P/E (1 yr):19.87
    P/S (ttm):12.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.21
    Quarterly EPS Est (Mar-16) :1.14
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.33

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback